Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00875095 · ClinicalTrials.gov registry record

Impact of Sperm DNA Integrity on Artificial Reproductive Treatment (ART)

A clinical trial, sponsored by Northwell Health.

Terminated
Registry status
8
Enrollment target

NCT00875095: Clinical Trial study, sponsored by Northwell Health.

NCT00875095 is a clinical trial that was terminated before completion, run by Northwell Health. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00875095 was terminated before completion, sponsored by Northwell Health.

TERMINATED
Registry status
8 participants
Enrollment target

Study Summary

The purpose of this study is to establish a new criteria with which to judge the quality of sperm samples submitted for artificial reproductive treatments. It is believed that this type of testing can compliment the traditional semen analysis to better drive patient care.

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2007-10
Est. Completion 2008-12
Northwell Health

370 total trials

Why NCT00875095 stopped before completion

NCT00875095 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00875095 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00875095 about?

NCT00875095 is a clinical study titled "Impact of Sperm DNA Integrity on Artificial Reproductive Treatment (ART)". The purpose of this study is to establish a new criteria with which to judge the quality of sperm samples submitted for artificial reproductive treatments. It is believed that this type of testing can compliment the traditional semen analysis to better drive patient care.

What is the current status of trial NCT00875095?

This trial is currently terminated. The enrollment target is 8 participants. The study started on 2007-10. Estimated completion is 2008-12.

Who is sponsoring clinical trial NCT00875095?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00875095, the US trial registry maintained by the National Library of Medicine. NCT00875095 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.